The Trump administration has restored federal family planning grants to Planned Parenthood, reversing course just months after attempting to block the funding and repeatedly describing itself as the “most pro-life administration” in U.S. history.

The decision centers on Title X, a long-standing federal program that provides funding for reproductive health services such as contraception, cancer screenings, and STI testing. Although Title X funds cannot be used to pay for abortions, the program has long been a flashpoint in the political fight over abortion access because some of its largest recipients, including Planned Parenthood, also provide abortion services through separate funding streams.

A White House spokesperson said the administration had little choice but to release the funds.

Kush Desai told reporters that while officials initially sought to withhold the grants, “significant legal challenges” made that effort untenable. Rather than risk another court battle, the administration opted to distribute the 2026 funding to recipients that had already been approved under prior agreements.

Those agreements date back to 2021, when the administration of Joe Biden awarded five-year Title X grants to Planned Parenthood and other reproductive health providers. The move was intended to reverse restrictions put in place during Trump’s first term, when federal rules limited the ability of organizations that provided or referred patients for abortions to participate in the program.

When Donald Trump returned to office, his administration moved quickly to cancel funding for 22 organizations that had received grants during the Biden era. That decision prompted legal challenges from reproductive rights groups, who argued that the government could not arbitrarily revoke funding already awarded under federal contracts.

The administration ultimately released those funds in December after facing pressure in court — a precedent that appears to have shaped its latest decision.

On Wednesday, officials confirmed they would again release Title X funds for 2026 rather than attempt another round of litigation. Desai said the administration still intends to “realign the Title X program with the President’s pro-life and pro-family agenda going forward,” signaling that broader policy changes could still be on the table.

It remains unclear how much funding Planned Parenthood and other organizations will receive from the latest allocation.

The debate over Title X funding has intensified in recent months as the administration also sought to eliminate the program entirely. In its 2026 budget proposal, the White House attempted to cut the $286 million allocated to Title X, but Congress ultimately preserved the funding in the final spending bill.

That outcome — combined with the administration’s decision to release the grants — has angered some anti-abortion advocates, who argue that any federal funding directed toward Planned Parenthood indirectly supports abortion access.

Marjorie Dannenfelser, president of the anti-abortion group SBA Pro-Life America, sharply criticized the move in a statement posted to social media.

She described the decision as a “political calculation” and an “inexplicable slap in the face to the pro-life GOP base,” arguing that the administration had failed to follow through on its earlier promises to restrict funding to organizations connected to abortion services.

“This is a clear abandonment,” Dannenfelser wrote, referencing policies from Trump’s first term that sought to block Title X funding from going to Planned Parenthood.

Reproductive health advocates, however, have long argued that Title X funding supports a wide range of essential health services that have nothing to do with abortion, particularly for low-income patients who rely on subsidized care.

For now, the administration’s decision reflects a familiar tension: a political commitment to restricting abortion access colliding with legal constraints and existing federal funding structures.

The result is a partial reversal — one that underscores the limits of executive power when it runs up against contracts, courts, and congressional appropriations.

And for both sides of the debate, it’s unlikely to be the final word.